Search results

Filter

Filetype

Your search for "*" yielded 539256 hits

Swedish Medical Products Agency grants approval for clinical study of new stem cell based Parkinson’s Disease treatment

Läkemedelsverket godkänner klinisk fas 1- och fas2a-studie för ny stamcellsbaserad behandling av Parkinsons sjukdom An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the STEM-PD team, l

https://www.regenerative-neurobiology.lu.se/article/swedish-medical-products-agency-grants-approval-clinical-study-new-stem-cell-based-parkinsons - 2025-10-01

First patient receives milestone stem cell-based transplant for Parkinson’s Disease

Lund University: Press release On 13th of February, 2023, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. Please go to the below links to find out more about STEM PD. English: https://www.lunduniversity.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease Svenska: https://www.l

https://www.regenerative-neurobiology.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease - 2025-10-01

Congratulations Fredrik!

2023-04-27. We are very happy to join Fredrik Nilsson for the nailing of his thesis "Cell Replacement Therapy for Parkinson's Disease: Evaluating the potential of autologous grafting". The defence will take place on May 10th, 2023 at 9.00 am at the Belfrage Lecture Hall (Klinikgatan 32, Lund) - you are very welcome to join! To access the thesis please go to Lund university's database:  Cell Replac

https://www.regenerative-neurobiology.lu.se/article/congratulations-fredrik - 2025-10-01

Congratulations Dr. Nilsson!

2023-05-10. We are very happy to announce that Fredrik Nilsson successfully defended his thesis "Cell Replacement Therapy for Parkinson's Disease: Evaluating the potential of autologous grafting" today. Congratulations Dr. Nilsson! To read an interview with Fredrik, please go to the following article: Investigating a cell replacement therapy for Parkinson's Disease: a Ph.D. Interview with Fredrik

https://www.regenerative-neurobiology.lu.se/article/congratulations-dr-nilsson - 2025-10-01

Malin Parmar and Roger Barker recieve the Oon Award for Preventative Medicine 2024

The prize was given in recognition of their pioneering work in researching neurodegenerative diseases and translational stem cell biology. For more information of the event, please see:https://www.dow.cam.ac.uk/news/experts-delve-advancements-parkinsons-treatment-oon-lecture 

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-and-roger-barker-recieve-oon-award-preventative-medicine-2024 - 2025-10-01

Klinisk stamcellsbaserad transplantationsstudie – STEM-PD – mot Parkinsons har inlett doshöjning

Positiva tidiga säkerhetsresultat har uppnåtts efter de fyra första patienterna som genomgått transplantation av dopaminproducerande stamceller inom den kliniska studien STEM-PD.För att läsa artikeln vänligen gå till: https://www.lu.se/artikel/klinisk-stamcellsbaserad-transplantationsstudie-stem-pd-mot-parkinsons-har-inlett-doshojning

https://www.regenerative-neurobiology.lu.se/article/klinisk-stamcellsbaserad-transplantationsstudie-stem-pd-mot-parkinsons-har-inlett-doshojning - 2025-10-01

Press release: ERC Synergy Grant awarded for the development of custom-made stem cell therapies

Malin Parmar, professor of cellular neuroscience, along with three researchers in Italy and Denmark, has been awarded the prestigious ERC Synergy Grant worth EUR 10 million. The four researchers aim to develop custom-made neurons from stem cells for cell therapies to treat Parkinson’s or Huntington’s disease. For full press release please go to the following page:https://www.lunduniversity.lu.se/a

https://www.regenerative-neurobiology.lu.se/article/press-release-erc-synergy-grant-awarded-development-custom-made-stem-cell-therapies - 2025-10-01

Celebrating our new grant from The Knut and Alice Wallenberg Foundation

We are very thrilled to be recepients of a prestigious grant awarded by The Knut and Alice Wallenberg Foundation! 2019-01-14. For this new and exciting project Malin Parmar's group will closely collaborate with Tomas Björklund's group. Both of the groups belong to the Department of Experimental Medical Science which is why we were very happy to celebrate the grant with the head of the department M

https://www.regenerative-neurobiology.lu.se/article/celebrating-our-new-grant-knut-and-alice-wallenberg-foundation - 2025-10-01

Besök hos Bålsta Parkinson Föreningen / Visit to Bålsa Parkinson's Society

Jenny Nelander Wahlestedt har idag besökt Bålsta Parkinson Föreningen där hon berättade om vår forskning för ca. 50 engagerade åhörare. Tack till Bålsta Parkinson Föreningen för att ni bjöd in oss! In English: Jenny Nelander Wahlestedt has today visited the Bålsta Parkinson's Society to talk to app. 50 participants about our research. Thank you for inviting us, Bålsta Parkinson's Society!

https://www.regenerative-neurobiology.lu.se/article/besok-hos-balsta-parkinson-foreningen-visit-balsa-parkinsons-society - 2025-10-01

New collaboration between Lund scientists and Novo Nordisk / Nytt samarbete mellan Lundaforskare och Novo Nordisk

Read here about how Novo Nordisk, together with the Swedish biotech company Biolamina in Stockholm, collaborates with Malin Parmar and her close collegues Agnete Kirkeby and Anders Björklund at Lund University to develop a new stem cell based treatment for Parkinson's disease.     for Lund University's press release please click here biolamina.pdf På svenska: Nytt samarbete mellan Lundaforskare oc

https://www.regenerative-neurobiology.lu.se/article/new-collaboration-between-lund-scientists-and-novo-nordisk-nytt-samarbete-mellan-lundaforskare-och - 2025-10-01

Thesis Defence Interview - Sara Nolbrant

Sara Nolbrant, from the Developmental and Regenerative Neurobiology lab, will be defending her PhD thesis on Friday 31st of January. Researching in the group led by Malin Parmar, Sara has been directing and dissecting the fate of dopaminergic neurons with the aim developing cell replacement therapy for the treatment of Parkinson’s disease. Here, Sara answers a few questions about her research and

https://www.regenerative-neurobiology.lu.se/article/thesis-defence-interview-sara-nolbrant - 2025-10-01